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Background: Novel bone substitutes have challenged the notion of autologous bone grafting as the ‘gold
standard’ for the surgical treatment of fracture nonunions. The present study was designed to test the hypothesis
that autologous bone grafting is equivalent to other bone grafting modalities in the management of fracture
nonunions of the long bones.
Methods: A retrospective review of patients with fracture nonunions included in two prospective databases was
performed at two US level 1 trauma centers from January 1, 1998 (center 1) or January 1, 2004 (center 2), respectively,
until December 31, 2010 (n = 574). Of these, 182 patients required adjunctive bone grafting and were stratified into the
following cohorts: autograft (n = 105), allograft (n = 38), allograft and autograft combined (n = 16), and recombinant
human bone morphogenetic protein-2 (rhBMP-2) with or without adjunctive bone grafting (n = 23). The primary
outcome parameter was time to union. Secondary outcome parameters consisted of complication rates and the rate of
revision procedures and revision bone grafting.
Results: The autograft cohort had a statistically significant shorter time to union (198 ± 172–225 days) compared to
allograft (416 ± 290–543 days) and exhibited a trend towards earlier union when compared to allograft/autograft
combined (389 ± 159–619 days) or rhBMP-2 (217 ± 158–277 days). Furthermore, the autograft cohort had the
lowest rate of surgical revisions (17%) and revision bone grafting (9%), compared to allograft (47% and 32%),
allograft/autograft combined (25% and 31%), or rhBMP-2 (27% and 17%). The overall new-onset postoperative infection
rate was significantly lower in the autograft group (12.4%), compared to the allograft cohort (26.3%) (P < 0.05).
Conclusion: Autologous bone grafting appears to represent the bone grafting modality of choice with regard to
safety and efficiency in the surgical management of long bone fracture nonunions.
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Fracture nonunions of long bones continue to represent
a significant clinical challenge and socioeconomic burden,
associated with high complication rates and the potential
for poor long-term outcomes [1-5]. Autologous bone
grafting has received a negative reputation in the past,
mainly due to the high risk of postoperative complications
related to the harvesting procedure [6]. However, more
recent innovative and minimally invasive harvesting
techniques have mitigated the historic issue of donor
site morbidity and renewed the interest in autologous
bone as a preferred source for bone grafting [7-9].
The introduction of new generation bone substitutes
and recombinant molecules with osteoinductive proper-
ties has recently challenged the role of autologous bone
grafting as the ‘gold standard’ for the surgical treatment
of nonunions [10-12]. In light of the immense market
potential for bone graft substitutes and related products,
estimated to be US$1 billion in the USA alone, the push for
new ‘osteobiologicals’ may in large part be industry-driven,
rather than based on objective patient safety and quality
data [13-15]. In fact, well-publicized concerns have recently
been raised regarding the safety of the uncritical application
of recombinant bone morphogenetic protein (BMP)-2 for a
variety of indications, including its off-label use [14,16-18].
The present study was designed to determine the ‘ideal’
modality of adjunctive bone grafting in the management of
long bone fracture nonunions. We hypothesized that the
use of autograft is equivalent to other bone grafting options
with regard to healing times and complication rates.
Methods
Study design
A retrospective cohort study was designed based on two
prospective institutional databases from representative
level 1 trauma centers in the USA (Denver Health Medical
Center, Denver, CO; and Geisinger Medical Center,
Danville, PA). Prior to study initiation, approval by the
two respective Institutional Review Boards was obtained.
The databases included all patients between 18 and 85
years of age, who were admitted to one of the two partici-
pating centers for surgical treatment of long bone fracture
nonunions between January 1, 1998 and December 31,
2010 (n = 373; Denver Health), and between January 1,
2004 and December 31, 2010 (n = 201; Geisinger),
respectively. Patients that did not require adjunctive
bone grafting (n = 362) or had a nonunion of the forearm
(n = 30) were excluded from the analysis. Patients who
were lost to follow-up prior to a minimum of 12 months
postoperatively or prior to clinical and radiographic union
were excluded. The remaining 182 patients who required
adjunctive bone grafting for nonunions of the tibia (n = 98),
femur (n = 46), or humerus (n = 38) were included for final
analysis. The flowchart in Figure 1 depicts the patientselection process in detail. Figures 2,3,4,5 illustrate a
representative case example of a 31-year-old male who
sustained an isolated type IIIB open segmental tibia frac-
ture. The patient underwent initial surgical debridement
and external fixation, followed by staged conversion to an
intramedullary nail. He developed a tibial nonunion,
requiring exchange nailing and autologous bone grafting.
In accordance with the definition by the US Federal
Drug Administration (FDA), nonunion was defined as a
fractured bone which had not completely healed within
9 months of injury and which had not shown signs of
progression towards healing for three consecutive months
on serial radiographs [19]. Nonunions were classified
according to the Weber and Cech classification system
into hypertrophic, normotrophic, or atrophic [19].
Nonunions were treated either by plate osteosynthesis
(using conventional plates or locking plate systems),
intramedullary nail fixation (including exchange nailing), or
by external ring fixator in combination with bone grafting,
based on the individual surgeon’s preference.
Patients were stratified into the following cohorts for
analysis, based on the bone grafting modality: (1) autograft
(n = 105), (2) allograft (n = 38), (3) allograft in combination
with autograft (n = 16), and (4) rhBMP-2 with or without
adjunctive bone grafting substitute (n = 23). The rhBMP-2
product was mixed with sterile saline and prepared imme-
diately prior to use from a kit containing all necessary
components, according to the manufacturer’s instructions
(Infuse®, Medtronic, Memphis, TN, USA). In 6 patients,
rhBMP-2 was administered without bone grafting adjunct,
while in the remaining 17 patients rhBMP-2 was combined
with allograft. All patients were followed postoperatively for
a minimum of 12 months, or until clinical and radiographic
bone healing occurred. ‘Clinical union’ was defined as
painless weight bearing and lack of local tenderness over
the nonunion site on physical examination [20,21]. ‘Radio-
graphic union’ was defined as bridging bone on a minimum
of three cortices on conventional antero-posterior and
lateral radiographs. The application of rhBMP-2 for the re-
vision of long bone fracture nonunions was considered an
‘off-label’ indication. Autograft donor sites were as follows:
(1) iliac crest (n = 64), (2) femoral reamer-irrigator-aspirator
(n = 20), and (3) other (n = 10). The primary outcome par-
ameter was time to union. The secondary outcome param-
eters included the incidence of new-onset postoperative
infection in a previously noninfected nonunion or ongoing
infection in infected nonunions, as well as the need of
revision surgeries and revision bone grafting.
Statistical analysis
Data were analyzed using SPSS software version 17.0
(SPSS Inc., Chicago, IL, USA). Descriptive statistics
were performed to summarize demographic and clinical
variables and to evaluate distributional characteristics of
Figure 1 Patient selection flowchart.
Figure 2 Representative case example. A 31-year-old male pedestrian was hit at high speed by a motor vehicle, sustaining an isolated type IIIB
open segmental tibia shaft fracture (A, B) with associated segmental fibula fracture (AO/OTA type 42-C2.2). The arrow in panel A depicts the
proximal nondisplaced fracture line of the segmental tibia fracture.
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Figure 3 Identical case as in Figure 2. After initial spanning external fixation and surgical debridement, the patient was taken back to the
operating room the next day for definitive surgical management by reamed intramedullary interlocking nail fixation (A, B), repeat surgical
debridement (C), and soft tissue coverage by free microvascular gracilis flap in the same session (D).
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Whitney U test, and Chi-square test, as appropriate. Data
are expressed as means ± standard deviation or means ±
95% confidence interval (95% CI), as deemed appropriate.
Statistical significance was defined at P < 0.05.
Results
Patient demographics
A total of 182 patients (102 males and 80 females) met the
inclusion criteria (Figure 1). The mean age was 44 ± 13.6
years. Sixty-eight patients were confirmed smokers, and 30
patients had a history of smoking and reported cessation
prior to nonunion surgery. The remaining 84 patients
reported to have never smoked. Demographic data, stratified
by subgroups, are depicted in Table 1. The surgical manage-
ment of the nonunions consisted of plate osteosynthesis
(65%), intramedullary interlocking nail fixation (28%),
or application of an external ring fixator (7%). Nonunion
characteristics and management strategies in the different
cohorts are shown in Table 2.
Patients in the autograft group had a significantly shorter
average time to union (198 days, 95% CI 172–225 days),
when compared to the allograft group (416 days, 95% CI
290–543 days), while no statistically significant differences
were found among the autograft group, the autograft/
allograft cohort (389 days, 95% CI 159–619 days), and
the rhBMP-2 cohort (217 days, 95% CI 158–277 days).Differences in time to healing were significant between
the autograft and allograft cohorts (P < 0.001).
Furthermore, the autograft group had a significantly
lower incidence of surgical revision rates (17.1%) and need
for revision bone grafting (8.6%) compared to the allograft
group (47.4% and 31.6%, respectively), the allograft/
autograft group (25.0% and 31.3%, respectively), and the
rhBMP-2 cohort (26.1% and 17.4%, respectively) (P < 0.01
for autograft vs. all other cohorts). Stratified by subgroups,
the incidence of new-onset postoperative infection after
nonunion surgery was highest in the allograft group (26.3%),
followed by the rhBMP-2 group (17.4%), autograft group
(12.4%), and was found to be lowest in the autograft/
allograft cohort (6.3%). These data were statistically signifi-
cant between autograft and allograft cohorts (P < 0.05) and
were further stratified by superficial and deep infection. A
summary of the outcome data is shown in Table 3.
Discussion
The present study was designed to analyze the efficacy
of distinct adjunctive bone grafting modalities for surgical
revisions of long bone fracture nonunions. Our data
revealed that in this particular patient population, the
use of autograft had a significantly shorter time to union
when compared to allograft, the lowest incidence of surgi-
cal revision rates and revision bone grafting, and the low-
est postoperative infection rates, compared to the allograft
Figure 4 Identical case as in Figures 2,3. At 5 months follow-up, the patient showed clinical and radiographic signs of a nonunion of the open
tibia fracture (A, B). A surgical revision was performed by exchange reamed nailing at 6 months (C, D).
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There was a statistically nonsignificant trend towards earlier
time to union in autograft patients compared to autograft/
allograft or rhBMP-2 cohorts. These findings support the
notion that autograft remains the gold standard for bone
grafting of nonunions [22], despite the emerging availability
of a multiplicity of novel osteobiologicals that have recently
received considerable attention as bone grafting adjuncts
[23]. The indication spectrum of human recombinant
rhBMP-2 remains highly controversial, particularly in
light of some recent concerns regarding its question-
able safety and efficiency profile [14,16-18]. The historic
‘rhBMP-2 Evaluation in Surgery for Tibial Trauma
(BESTT)’ multicenter prospective randomized trial on 450
patients with open tibial fractures managed by unreamed
interlocking nail fixation revealed that the local application
of rhBMP-2 resulted in a significant reduction of nonunion
rates [24]. Jones et al. reported the results from a random-
ized, controlled clinical trial on 30 patients, which revealed
that rhBMP-2 in combination with allograft had similar
times to union and outcomes compared to autograft intibial shaft fractures with cortical defects [25]. A more
recent prospective, randomized trial failed to demonstrate
accelerated healing in open tibia fractures treated by
reamed intramedullary nailing and rhBMP-2, confirming
the notion that reaming represents a more crucial par-
ameter for successful fracture healing, rather than the
adjunctive use of rhBMP-2 [26].
Our present study supports the notion that autograft
remains at least as effective as rhBMP-2, with similar
time to union and decreased incidence of postoperative
complications and requirement for surgical revisions. These
findings are challenged by a different recent publications,
which compared rhBMP-2 with cancellous allograft and
iliac crest autograft in a retrospective study of 89 patients
with long bone nonunions [27].The authors failed to find a
difference in union rates between the treatment groups and
reported an increased incidence of postoperative infections
in the autologous iliac crest bone grafting group, compared
to the rhBMP-2/allograft cohort [27]. In addition, iliac
crest autograft was associated with longer operative proce-
dures and a higher amount of intraoperative blood loss.
Figure 5 Identical case as in Figures 2,3,4. The nonunion persisted at 11 months post injury, and a second revision was performed by
decortication and application of a central bone graft (A, B), using a reamer-irrigator-aspirator technique for minimal invasive autograft harvest
from the ipsilateral femur. The fracture/nonunion was clinically and radiographically healed at 19 months post injury (C, D), and the patient was
asymptomatic with a full functional recovery.
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viable alternative to autologous iliac bone grafting in
the management of long bone nonunions [27].
The lack of long-term safety and efficiency data on the
use of BMPs as bone grafting adjuncts, in conjunction
with realistic concerns that BMPs may be associated with
the long-term induction of bone tumors [28,29], substan-
tiates the ongoing discussion against liberal application of
BMPs until long-term data are available [16,30]. Ritting
et al. recently published a pediatric case report describ-
ing a massive local inflammatory reaction after use of
rhBMP-2 for repair of a symptomatic forearm nonunion in
a child [31]. Such serious complications question the
standard use of rhBMP-2 as routine bone grafting ad-
juncts in nonunion surgery.
Demineralized bone matrix (DBM) represents the most
commonly used bone substitute with osteoinductive prop-
erties [32]. With the use of DBM, however, an adjunctive
scaffold is needed to add osteoconductive properties
[32]. Comparison of combined osteogenic products
have demonstrated significant differences in osteogenicpotential, depending on processing techniques, carriers,
sterilization methods, and storage conditions [33,34]. Such
variations result in considerable inconsistency in product
safety and efficiency. Bae and colleagues recently reported
substantial ‘lot-to-lot’ variability in terms of BMP concen-
trations and in vivo fusion rates in DBM/BMP products,
challenging the reliability of such adjuncts in bone
grafting [35,36].
Autograft possesses the combined osteogenic properties
of osteoinduction and osteoconduction, thus representing
superior mechanical and biologic properties than any
allogeneic or synthetic bone substitutes [37]. Traditionally,
autograft was harvested from the iliac crest, providing
sizeable quantities of autograft and the possibility of a
tricortical structural grafting [38]. However, disadvantages
of using the iliac crest as a donor site are well established
in the literature and include persistent pain, infections,
and the induction of iatrogenic pelvic fractures and
nonunions [6,39,40].
An emerging alternative to iliac crest harvesting is rep-
resented by the Reamer-Irrigator-Aspirator (RIA) system,
Table 1 Patient demographics and fracture characteristics
Variable Overall Autograft Allograft Autograft/allograft rhBMP-2
Gender
Male 102 (56%) 58 (55%)* 16 (42%) 4 (25%) 7 (30%)
Female 80 (44%) 47 (45%)* 22 (58%) 12 (75%) 16 (70%)
Mean age (years) 44 (±13.6) 41 (±12.5)* 47 (±13) 46 (±14) 52 (±15)
EtOH
Abuse 44 (24%) 22 (21%) 8 (21%) 0 5 (22%)
Occasionally 45 (25%) 30 (29%) 12 (32%) 6 (37%) 6 (26%)
Never 97 (51%) 53 (50%) 18 (47%) 10 (63%) 12 (52%)
Tobacco smoking
Current 68 (37%) 41 (39%) 16 (42%) 4 (25%) 6 (26%)
Former 30 (17%) 17 (16%) 4 (11%) 4 (25%) 5 (22%)
Never 84 (46%) 47 (45%) 18 (47%) 8 (50%) 12 (52%)
Illicit drug use
Current 28 (15%) 17 (16%) 9 (24%) 0** 1 (4%)
Former 7 (4%) 6 (6%) 0 0** 1 (4%)
Never 147 (81%) 82 (78%) 29 (76%) 16 (100%) 21 (92%)
Injury mechanism
MVA/MCA 83 (46%) 49 (47%) 18 (47%) 8 (50%) 8 (35%)
Fall 39 (21%) 20 (19%) 10 (26%) 3 (19%) 6 (26%)
GSF 6 (3%) 5 (4%) 1 (3%) 0 0
Other 33 (18%) 31 (30%) 9 (24%) 5 (31%) 9 (39%)
Fracture location
Tibia 98 (54%) 57 (54%) 21 (55%) 9 (56%) 11 (48%)
Femur 46 (25%) 28 (27%) 9 (24%) 4 (25%) 5 (22%)
Humerus 38 (21%) 20 (19%) 8 (21%) 3 (19%) 7 (30%)
Fracture characteristics
Open 79 (43%) 51 (49%) 17 (45%) 4 (25%) 7 (30%)
Closed 103 (57%) 54 (51%) 21 (55%) 12 (75%) 16 (70%)
MVA motor vehicle accident, MCA motorcycle accident, GSF gunshot fracture, rhBMP-2 recombinant human bone morphogenetic protein-2.
*(P < 0.05), statistically significant difference among autograft cohort vs. allograft, autograft/allograft, and BMP-2 cohorts.
** (P < 0.05) statistically significant difference between autograft/allograft group and remaining cohorts.
Table 2 Nonunion characteristics and management strategies
Variable Overall (%) Autograft (%) Allograft (%) Allograft/autograft (%) rhBMP-2 (%)
Nonunion classification
Atrophic 55 (30) 35 (34) 11 (29) 4 (25) 6 (26)
Normotrophic 75 (41) 44 (42) 16 (43) 7 (44) 9 (39)
Hypertrophic 21 (12) 13 (12) 4 (10) 2 (12) 2 (9)
Infected 31 (17) 13 (12) 7 (18) 3 (19) 6 (26)
Initial surgical fracture management
Plate 119 (65) 79 (75) 22 (58) 6 (38) 13 (57)
IMN 50 (28) 19 (18) 13 (34) 8 (50) 9 (39)
Ring fixator 13 (7) 7 (7) 3 (8) 2 (12) 1 (4)
IMN intramedullary nail, rhBMP-2 recombinant human bone morphogenetic protein-2.
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Table 3 Outcome parameters
Variable Autograft Allograft Autograft/allograft rhBMP-2
n 105 38 16 23
Time to union in days (mean ± 95% CI) 198* (172–225) 416 (290–543) 389 (159–619) 217 (158–277)
Surgical revision rate (any unplanned return to the OR) 18** (17.1%) 18 (47.4%) 4 (25.0%) 6 (26.1%)
Revision bone grafting/nonunion rate 9** (8.6%) 12 (31.6%) 5 (31.3%) 4 (17.4%)
New-onset postoperative infection 13*** (12.4%) 10 (26.3%) 1 (6.3%) 4 (17.4%)
Superficial 5 (4.8%) 1 (2.6%) 0 (0%) 0 (0%)
Deep 8 (7.6%) 9 (23.7%) 1 (6.3%) 4 (17.4%)
Persisting infection 3 (2.9%) 3 (7.9%) 1 (6.3%) 1 (4.3%)
rhBMP-2 recombinant human bone morphogenetic protein-2.
Data in the time to union row are expressed as mean ± 95% CI.
* (P < 0.001), statistically significant between autograft and allograft cohorts.
** (P < 0.01), statistically significant between autograft and all other cohorts.
*** (P < 0.05), statistically significant between autograft and allograft groups.
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graft from the intramedullary femoral canal [7,41].
Compared to iliac crest harvest, the RIA produces com-
parable volumes of bone graft and comparable harvesting
times, but with a markedly reduced incidence of postoper-
ative pain and lower rates of postoperative complications
[42]. The grafting material obtained by RIA possesses
osteogenic properties and, although morselized, appears to
provide three-dimensional properties similar to trabecular
bone and offers the presence of osteoinductive BMPs and
growth factors in the grafting material [43,44].
Our study has several limitations. First, the retrospective
nature of the study design is associated with the known
pitfalls of any retrospective analysis and thus limits the
scientific value of the conclusions. Secondly, our study
includes data from two different level 1 trauma centers,
adding not only increased surgeon variability, but also
resulting in significant differences in the modality of
data acquisition between the study sites. On the other
hand, this weakness may, at the same time, represent a
strength, since the inclusion of two different study sites
may adjust for confounding variables specific to a single
institution, and thus make the findings more generally
applicable. Another drawback of our study is the combined
analysis of three different long bones with unequal bio-
mechanical and biological properties with regard to the
exposure to axial loading (femur, tibia) vs. rotational
forces (humerus), quality of the surrounding soft tissue
envelope and blood flow to the fracture site, etc. However,
when attempting a subanalysis for individual long bones
(humerus vs. femur vs. tibia), the sample sizes and power
became too small to make reasonable statistical assump-
tions without the risk of a type-II error. In line, while differ-
ences exist between gender distribution and age between
cohorts, subanalyses rendered patient numbers and power
too small to extract meaningful statistical data without
significant risk for a type-II error. Moreover, the incidence
of surgical revision in the autograft group may have beenreduced as these patients have received the current
gold standard treatment. Finally, there is the possibility
of selection bias in the present study. As bone grafting
modality was left to the treating surgeon’s discretion, it
is possible that patients were treated differently based
upon various pre-existing patient factors. As this is a
nonrandomized retrospective study, it is difficult to address
these factors. In an attempt to shed light on possible
differences in demographics and pre-existing social
factors, patients in all groups were analyzed for gender
and social factors, such as smoking status, intravenous
drug use, and alcohol abuse. There were statistically
significant differences (P < 0.05) between autograft cohort
vs. allograft, autograft/allograft, and BMP-2 cohorts
with regards to age and gender. In addition, a statistically
significant difference (P < 0.05) was found between the
illicit drug use status in the autograft/allograft group
and remaining cohorts. All other demographics (smoking
and alcohol abuse) failed to demonstrate any statistically
significant differences.
Nevertheless, our study provides valuable insights into
the efficacy of different bone grafting adjuncts in nonunion
surgery of long bones, implying that the use of autograft
as a grafting adjunct may continue to represent the best
practice until higher quality data are available.
Conclusion
Autograft appears to represent the most efficacious bone
grafting adjunct for nonunion surgery of long bones. Time
to union, need for revision surgery, and revision bone
grafting, as well as new onset or continuing postoperative
infection rates were most favorable when autograft was
used, compared to allograft, combined autograft/allograft,
or rhBMP-2. In light of the growing critical reviews related
to the safety and efficacy of rhBMP-2 in other indications,
namely in spine surgery, the use of this product should be
critically evaluated prior to surgical revision of long bone
fracture nonunions.
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